Adaptyv raises $40M Series A to build the automated lab for agentic biology
Share this article
The Biopôle-based startup announced a $40M Series A funding round to build the automated lab for agentic biology, led by Highland Europe, with existing investors Ace Ventures, ByFounders and Y Combinator doubling down.
Last week, they shared their work with Anthropic. Claude designed proteins, sent them to Adaptyv‘s automated wet lab, and got real experimental data back.
They believe this is where biology is going: AI agents designing experiments, running them in automated wet labs, learning from the results and iterating.
But AI can only move as fast as the experiments behind it. To use the potential of AI to cure all diseases, there’s a need to build high-throughput wet lab infrastructure: a “biological gigafactory”. That’s exactly what Adaptyv is doing.
Over the past year they have grown their lab throughput by over 5x and onboarded more than 100 customers, ranging from bio AI labs like Chai Discovery and Boltz to pharmas like Roche and Novo Nordisk to dozens and dozens of new startups that use AI to radically speed up drug discovery.
Now they are scaling: doubling their team in Lausanne and opening a new office and lab in London in Q4 2026.
➡️ Source: Press Release